Innocoll Holdings plc Announces Closing of Public Offering
22 juin 2016 16h30 HE
|
Innocoll Holdings plc
ATHLONE, Ireland, June 22, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a specialty pharmaceutical and medical device company with late stage development programs targeting areas...
Innocoll Holdings plc Announces Pricing of Public Offering of Ordinary Shares
16 juin 2016 22h00 HE
|
Innocoll Holdings plc
ATHLONE, Ireland, June 16, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical and medical device company with late stage development programs...
Innocoll Holdings plc to Present at the JMP Securities Life Sciences Conference
16 juin 2016 09h20 HE
|
Innocoll Holdings plc
ATHLONE, Ireland, June 16, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL) a global, specialty pharmaceutical and medical device company with late stage development programs targeting...
Innocoll Holdings plc Announces Proposed Public Offering of Ordinary Shares
13 juin 2016 16h15 HE
|
Innocoll Holdings plc
ATHLONE, Ireland, June 13, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL) a global, specialty pharmaceutical and medical device company with late stage development programs targeting...
Innocoll Holdings plc Announces First Quarter 2016 Financial and Operating Results and Provides Corporate Update
31 mai 2016 16h05 HE
|
Innocoll Holdings plc
ATHLONE, Ireland, May 31, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical company with late stage development programs targeting areas of...
Innocoll Announces XARACOLL® (bupivacaine-collagen bioresorbable implant) Meets Primary Endpoint in Both Pivotal Phase 3 Trials in Postoperative Pain Relief
25 mai 2016 07h30 HE
|
Innocoll Holdings plc
First long-acting, opioid-sparing, local analgesic to meet primary endpoints of Phase 3 clinical trials in hernia repairData supports on-schedule NDA filing this yearResults validate the Innocoll...
Innocoll to Host Live Webcast on Top-Line Results from Two Pivotal Phase 3 Trials of XARACOLL® (bupivacaine-collagen bioresorbable implant) in Postoperative Pain Relief
24 mai 2016 16h15 HE
|
Innocoll Holdings plc
ATHLONE, Ireland, May 24, 2016 (GLOBE NEWSWIRE) -- Innocoll (NASDAQ:INNL), a global, commercial-stage, specialty pharmaceutical company, today announced that the Company will host a live webcast...
Innocoll to Report First Quarter 2016 Financial Results and Host Webcast and Conference Call on May 31, 2016
18 mai 2016 16h10 HE
|
Innocoll Holdings plc
ATHLONE, Ireland, May 18, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, commercial-stage, specialty pharmaceutical company that develops and manufactures a range of...
Innocoll Holdings plc Appoints Lesley Russell, MBChB, MRCP, as Chief Medical Officer
20 avr. 2016 16h43 HE
|
Innocoll Holdings plc
ATHLONE, Ireland, April 20, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical company with late stage development programs targeting areas of...
Innocoll Holdings plc Announces Fourth Quarter and Full-Year 2015 Financial and Operating Results and Provides Corporate Update
17 mars 2016 08h00 HE
|
Innocoll Holdings plc
ATHLONE, Ireland, March 17, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical company with late stage development programs targeting areas of...